Fasting GH concentration <36.6 μg/L and DG tumor turned out to be independent predictors of good response to first-generation SRLs (OR=0.96, p=0.06 and OR=10.68, p=0.002, respectively). The gene discussed is GH1; the disease is neoplasm.